ICCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
IceCure Medical Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 17, 2026
$1.08+0.02 (+1.89%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 0.1
- Dividend yield
- –
IceCure Medical Ltd. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|
| Disposables [Member] | $2.05M | $1.83M | $1.50M | $1.34M | $1.21M | 60.8% | +12.3% |
| Systems [Member] | $1.33M | $1.36M | $1.45M | $1.00M | $1.56M | 39.2% | -2.7% |
| Exclusive distribution agreement and other services [Member] | – | $100.00K | $274.00K | $747.00K | $1.37M | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|
| Other [Member] | $1.94M | $1.46M | $1.42M | $1.17M | $1.22M | 57.3% | +33.0% |
| United States | $908.00K | $870.00K | $751.00K | $604.00K | $471.00K | 26.9% | +4.4% |
| Japan | $282.00K | $481.00K | $480.00K | $1.13M | $1.38M | 8.3% | -41.4% |
| India | $120.00K | $413.00K | $109.00K | $47.00K | – | 3.6% | -70.9% |
| China | $108.00K | $41.00K | $440.00K | $104.00K | – | 3.2% | +163.4% |
| Israel | $24.00K | $30.00K | $30.00K | $30.00K | $108.00K | 0.7% | -20.0% |
| Thailand | – | – | $14.00K | $30.00K | $964.00K | – | – |
From the segment and revenue-disaggregation notes of IceCure Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.